281
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Menopausal symptoms and attitudes toward hormone replacement therapy among Israeli women

ORCID Icon, , , &
Pages 1-13 | Received 19 Oct 2021, Accepted 01 Jun 2023, Published online: 15 Jun 2023

References

  • Avis, N. E., Crawford, S. L., Greendale, G., Bromberger, J. T., Everson-Rose, S. A., Gold, E. B., Hess, R., Joffe, H., Kravitz, H. M., Tepper, P. G., & Thurston, R. C. (2015). Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Internal Medicine, 175(4), 531–539. https://doi.org/10.1001/jamainternmed.2014.8063
  • Baron-Epel, O., Garty, N., & Green, M. S. (2007, June). Inequalities in use of health services among Jews and Arabs in Israel. Health Services Research, 42(3 Pt 1), 1008–1019. https://doi.org/10.1111/j.1475-6773.2006.00645.x
  • Biglia, N., Cagnacci, A., Gambacciani, M., Lello, S., Maffei, S., & Nappi, R. E. (2017). Vasomotor symptoms in menopause: A biomarker of cardiovascular disease risk and other chronic diseases? Climacteric: The Journal of the International Menopause Society, 20(4), 306–312. https://doi.org/10.1080/13697137.2017.1315089
  • Bromberger, J. T., Schott, L. L., Avis, N. E., Crawford, S. L., Harlow, S. D., Joffe, H., Kravitz, H. M., & Matthews, K. A. (2019). Psychosocial and health-related risk factors for depressive symptom trajectories among midlife women over 15 years: Study of Women’s Health Across the Nation (SWAN). Psychological Medicine, 49(2), 250–259. https://doi.org/10.1017/S0033291718000703
  • Bromberger, J. T., Schott, L. L., Kravitz, H. M., Sowers, M., Avis, N. E., Gold, E. B., Randolph, J. F., & Matthews, K. A. (2010). Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: Results from the Study of Women’s Health Across the Nation (SWAN). Archives of General Psychiatry, 67(6), 598–607. https://doi.org/10.1001/archgenpsychiatry.2010.55
  • Bursac, Z., Gauss, C. H., Williams, D. K., & Hosmer, D. W. (2008). Purposeful selection of variables in logistic regression. Source Code for Biology and Medicine, 3, 17. https://doi.org/10.1186/1751-0473-3-17
  • Cagnacci, A., & Venier, M. (2019). The controversial history of hormone replacement therapy. Medicina, 55(9), 602. https://doi.org/10.3390/medicina55090602
  • Chaikittisilpa, S., Jirapinyo, M., Chaovisitsaree, S., Wipatavit, V., Bunyaviroch, S., Kanluan, B., Panyakhamlerd, K., Jaisamrarn, U., & Taechakraichana, N. (2007). Impact of women’s health initiative study on attitude and acceptance of hormone replacement therapy in Thai women attending menopause clinics. Journal of the Medical Association of Thailand, 90(4), 628–635.
  • El Khoudary, S. R., Greendale, G., Crawford, S. L., Avis, N. E., Brooks, M. M., Thurston, R. C., Karvonen-Gutierrez, C., Waetjen, L. E., & Matthews, K. (2019). The menopause transition and women’s health at midlife: A progress report from the Study of Women’s Health Across the Nation (SWAN). Menopause, 26(10), 1213–1227. https://doi.org/10.1097/GME.0000000000001424
  • Freeman, E. W., & Sherif, K. (2007). Prevalence of hot flushes and night sweats around the world: A systematic review. Climacteric: The Journal of the International Menopause Society, 10(3), 197–214. https://doi.org/10.1080/13697130601181486
  • Freeman, E. W., Sammel, M. D., Lin, H., Gracia, C. R., Kapoor, S., & Ferdousi, T. (2005). The role of anxiety and hormonal changes in menopausal hot flashes. Menopause, 12(3), 258–266. https://doi.org/10.1097/01.gme.0000142440.49698.b7
  • Garamszegi, C., Dennerstein, L., Dudley, E., Guthrie, J. R., Ryan, M., & Burger, H. (1998). Menopausal status: subjectively and objectively defined. Journal of Psychosomatic Obstetrics and Gynaecology, 19(3), 165–173. https://doi.org/10.3109/01674829809025694
  • Gold, E. B., Colvin, A., Avis, N., Bromberger, J., Greendale, G. A., Powell, L., Sternfeld, B., & Matthews, K. (2006). Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: Study of Women’s Health Across the Nation. American Journal of Public Health, 96(7), 1226–1235. https://doi.org/10.2105/AJPH.2005.066936
  • Green, R., Polotsky, A. J., Wildman, R. P., McGinn, A. P., Lin, J., Derby, C., Johnston, J., Ram, K. T., Crandall, C. J., Thurston, R., Gold, E., Weiss, G., & Santoro, N. (2010). Menopausal symptoms within a Hispanic cohort: SWAN, the Study of Women’s Health Across the Nation. Climacteric: The Journal of the International Menopause Society, 13(4), 376–384. https://doi.org/10.3109/13697130903528272
  • Harlow, S. D., Gass, M., Hall, J. E., Lobo, R., Maki, P., Rebar, R. W., Sherman, S., Sluss, P. M., & de Villiers, T. J. (2012). Executive summary of the Stages of Reproductive Aging Workshop + 10: Addressing the unfinished agenda of staging reproductive aging. The Journal of Clinical Endocrinology and Metabolism, 97(4), 1159–1168. https://doi.org/10.1210/jc.2011-3362
  • Hooper, S. C., Marshall, V. B., Becker, C. B., LaCroix, A. Z., Keel, P. K., & Kilpela, L. S. (2022). Mental health and quality of life in postmenopausal women as a function of retrospective menopause symptom severity. Menopause, 29(6), 707–713. https://doi.org/10.1097/GME.0000000000001961
  • Huang, W. F., Tsai, Y. W., Hsiao, F. Y., & Liu, W. C. (2007, April 17). Changes of the prescription of hormone therapy in menopausal women: An observational study in Taiwan. BMC Public Health, 7, 56. https://doi.org/10.1186/1471-2458-7-56
  • Israel Center for Disease Control (2012). Israel National Health Interview Survey INHIS-2 2007–2010-Selected Findings (Publication no. 331). Ministry of Health. Retrieved from https://www.health.gov.il/publicationsfiles/inhis_2.pdf
  • Kelly, M. J., Dunstan, F. D., Lloyd, K., & Fone, D. L. (2008). Evaluating cutpoints for the MHI-5 and MCS using the GHQ-12: A comparison of five different methods. BMC Psychiatry, 8, 10. https://doi.org/10.1186/1471-244X-8-10
  • Lin, L., Feng, P., & Yu, Q. (2020, December). Attitude and knowledge for menopause management among health professionals in mainland China. Climacteric: The Journal of the International Menopause Society, 23(6), 614–621. https://doi.org/10.1080/13697137.2020.1775809
  • Liu, Y., Ma, L., Yang, X., Bie, J., Li, D., Sun, C., Zhang, J., Meng, Y., & Lin, J. (2019). Menopausal hormone replacement therapy and the risk of ovarian cancer: A meta-analysis. Frontiers in Endocrinology, 10, 801. https://doi.org/10.3389/fendo.2019.00801
  • Lock, M., & Kaufert, P. (2001, July–August). Menopause, local biologies, and cultures of aging. American Journal of Human Biology, 13(4), 494–504. https://doi.org/10.1002/ajhb.1081
  • Manson, J. E., Chlebowski, R. T., Stefanick, M. L., Aragaki, A. K., Rossouw, J. E., Prentice, R. L., Anderson, G., Howard, B. V., Thomson, C. A., LaCroix, A. Z., Wactawski-Wende, J., Jackson, R. D., Limacher, M., Margolis, K. L., Wassertheil-Smoller, S., Beresford, S. A., Cauley, J. A., Eaton, C. B., Gass, M., … Wallace, R. B. (2013). Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials. JAMA, 310(13), 1353–1368. https://doi.org/10.1001/jama.2013.278040
  • Moilanen, J., Aalto, A. M., Hemminki, E., Aro, A. R., Raitanen, J., & Luoto, R. (2010). Prevalence of menopause symptoms and their association with lifestyle among Finnish middle-aged women. Maturitas, 67(4), 368–374. https://doi.org/10.1016/j.maturitas.2010.08.007
  • Muka, T., Oliver-Williams, C., Colpani, V., Kunutsor, S., Chowdhury, S., Chowdhury, R., Kavousi, M., & Franco, O. H. (2016). Association of vasomotor and other menopausal symptoms with risk of cardiovascular disease: A systematic review and meta-analysis. PLoS One, 11(6), e0157417. https://doi.org/10.1371/journal.pone.0157417
  • Namazi, M., Sadeghi, R., & Behboodi Moghadam, Z. (2019, December 9). Social determinants of health in menopause: An integrative review. International Journal of Women’s Health, 11, 637–647. https://doi.org/10.2147/IJWH.S228594
  • Nir-Caein, R., Nahum, R., Yogev, Y., Rosenfeld, J., Fisher, M., & Kaplan, B. (2002). Ethnicity and attitude toward menopause and hormone replacement therapy in Northern Israel. Clinical and Experimental Obstetrics & Gynecology, 29(2), 91–94.
  • Pinkerton, J. V. (2020). Hormone therapy for postmenopausal women. The New England Journal of Medicine, 382(5), 446–455. https://doi.org/10.1056/NEJMcp1714787
  • Rossouw, J. E., Anderson, G. L., Prentice, R. L., LaCroix, A. Z., Kooperberg, C., Stefanick, M. L., Jackson, R. D., Beresford, S. A. A., Howard, B. V., Johnson, K. C., Kotchen, J. M., & Ockene, J. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women’s Health Initiative randomized controlled trial. JAMA, 288(3), 321–333. https://doi.org/10.1001/jama.288.3.321
  • Sarri, G., Pedder, H., Dias, S., Guo, Y., & Lumsden, M. A. (2017). Vasomotor symptoms resulting from natural menopause: A systematic review and network meta-analysis of treatment effects from the National Institute for Health and Care Excellence guideline on menopause. BJOG: An International Journal of Obstetrics and Gynaecology, 124(10), 1514–1523. https://doi.org/10.1111/1471-0528.14619
  • Sharman Moser, S., Chodick, G., Bar-On, S., & Shalev, V. (2020). Healthcare utilization and prevalence of symptoms in women with menopause: A real-world analysis. International Journal of Women’s Health, 12, 445–454. https://doi.org/10.2147/IJWH.S246113
  • Soules, M. R., Sherman, S., Parrott, E., Rebar, R., Santoro, N., Utian, W., & Woods, N. (2001). Executive summary: Stages of Reproductive Aging Workshop (STRAW). Climacteric, 4(4), 267–272. https://doi.org/10.1080/cmt.4.4.267.272
  • Tang, R., Luo, M., Li, J., Peng, Y., Wang, Y., Liu, B., Liu, G., Wang, Y., Lin, S., & Chen, R. (2020). Relationships between vasomotor symptoms and mood in midlife urban Chinese women: Observations in a prospective study. Journal of Clinical Endocrinology and Metabolism., 105(11), dgaa554.
  • The NAMS 2017 Hormone Therapy Position Statement Advisory Panel (2017). The 2017 hormone therapy position statement of The North American Menopause Society. Menopause, 24(7), 728–753.
  • Thurston, R. C., & Joffe, H. (2011). Vasomotor symptoms and menopause: Findings from the Study of Women’s Health Across the Nation. Obstetrics and Gynecology Clinics of North America, 38(3), 489–501. https://doi.org/10.1016/j.ogc.2011.05.006
  • Wang, K., Li, F., Chen, L., Lai, Y. M., Zhang, X., & Li, H. Y. (2017). Change in risk of breast cancer after receiving hormone replacement therapy by considering effect-modifiers: A systematic review and dose-response meta-analysis of prospective studies. Oncotarget, 8(46), 81109–81124. https://doi.org/10.18632/oncotarget.20154
  • WHO Expert Consultation (2004). Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet, 363(9403), 157–163. https://doi.org/10.1016/S0140-6736(03)15268-3
  • Woods, N. F., & Mitchell, E. S. (2005). Symptoms during the perimenopause: Prevalence, severity, trajectory, and significance in women’s lives. The American Journal of Medicine, 118 Suppl 12B, 14–24. https://doi.org/10.1016/j.amjmed.2005.09.031
  • Yamazaki, S., Fukuhara, S., & Green, J. (2005). Usefulness of five-item and three-item Mental Health Inventories to screen for depressive symptoms in the general population of Japan. Health and Quality of Life Outcomes, 3, 48. https://doi.org/10.1186/1477-7525-3-48
  • Yu, Q., & Lin, L. (2022). The promotion of menopausal hormone therapy might be determined by the attitude of health-care professionals. Climacteric: The Journal of the International Menopause Society, 25(3), 213–214. https://doi.org/10.1080/13697137.2022.2057038
  • Zhang, L., Ruan, X., Cui, Y., Gu, M., & Mueck, A. O. (2020). Menopausal symptoms and associated social and environmental factors in midlife Chinese women. Clinical Interventions in Aging, 15, 2195–2208. https://doi.org/10.2147/CIA.S278976
  • Zhang, Y., Zhao, X., Leonhart, R., Nadig, M., Wang, J., Zhao, Y., Wirsching, M., & Fritzsche, K. (2019, February). A cross-cultural comparison of climacteric symptoms, health-seeking behavior, and attitudes towards menopause among Mosuo women and Han Chinese women in Yunnan, China. Transcultural Psychiatry, 56(1), 287–301. https://doi.org/10.1177/1363461518804094

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.